The stimulant e ects of ca eine on locomotor behaviour in mice are mediated through its blockade of adenosine A 2 A receptors

M. Yacoubi,C. Ledent,M. Parmentier,J. Costentin,J. Vaugeois

Abstract:1 The locomotor stimulatory e€ects induced by ca€eine (1,3,7-trimethylxanthine) in rodents have been attributed to antagonism of adenosine A1 and A2A receptors. Little is known about its locomotor depressant e€ects seen when acutely administered at high doses. The roles of adenosine A1 and A2A receptors in these activities were investigated using a Digiscan actimeter in experiments carried out in mice. Besides ca€eine, the A2A antagonist SCH 58261 (5-amino-7-(b-phenylethyl)-2-(8furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine), the A1 antagonist DPCPX (8-cyclopentyl-1,3dipropylxanthine), the A1 agonist CPA (N -cyclopentyladenosine) and A2A receptor knockout mice were used. 2 Ca€eine had a biphasic e€ect on locomotion of wild-type mice not habituated to the open ®eld, stimulating locomotion at 6.25 ± 25 mg kg i.p. doses, while depressing it at 100 mg kg. In sharp contrast, ca€eine dose-dependently decreased locomotion in A2A receptor knockout mice over the whole range of tested doses. 3 The depressant e€ects induced by high doses of ca€eine were lost in control CD1 mice habituated to the open ®eld. 4 The A1 agonist CPA depressed locomotion at 0.3 ± 1 mg kg 71 i.p. doses. 5 The A1 antagonist DPCPX decreased locomotion of A2A receptor knockouts and CD1 mice at 5 mg kg i.p. and 25 mg kg i.p. respectively. 6 DPCPX (0.2 ± 1 mg kg i.p.) left unaltered or even reduced the stimulant e€ect of SCH 58261 (1 ± 3 mg kg i.p.) on CD1 mice. 7 These results suggest therefore that the stimulant e€ect of low doses of ca€eine is mediated by A2A receptor blockade while the depressant e€ect seen at higher doses under some conditions is explained by A1 receptor blockade. British Journal of Pharmacology (2000) 129, 1465 ± 1473